LakeShore Biopharma Co., LtdLakeShore Biopharma Co., LtdLakeShore Biopharma Co., Ltd

LakeShore Biopharma Co., Ltd

No trades
See on Supercharts

LSB fundamentals

LakeShore Biopharma Co., Ltd financial statements, including revenue, expenses, profit, and loss

The total revenue of LSB for the last quarter is 18.97 M USD, and it's 20.35% lower compared to the previous quarter. The net income of Q4 23 is -25.47 M USD.

Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q3 '23
Q4 '23
‪0.00‬
Total revenue
Gross profit
Operating income
Pretax income
Net income
Currency: USD
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q3 '23
Q4 '23
TTM
Total revenueYoY growth
Gross profitYoY growth
Pretax incomeYoY growth
Net incomeYoY growth
EBITDAYoY growth
EBITYoY growth